🇺🇸 FDA
Patent

US 11045425

Method of encapsulating pancreatic islet cells introduced to siRNA against PHLDA3

granted A61KA61K2121/00A61K31/7088

Quick answer

US patent 11045425 (Method of encapsulating pancreatic islet cells introduced to siRNA against PHLDA3) held by KURARAY CO., LTD. expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
KURARAY CO., LTD.
Grant date
Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2121/00, A61K31/7088, A61K31/7105, A61K35/39